BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
EGFR
,
Apoptosis
,
HIV infection
,
Hippocampus
,
Hematopoietic cell
,
Doxycycline
,
rs6983267
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pentolinium
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CHRNA10
PA2G4P2
S100A8
APP
TRMT2B
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN
response to mechanical stimulus
NKX25_02
VEGF_A_UP.V1_DN
MORF_MAGEA9
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
Divergent splanchnic sympathetic efferent nerve pathways regulate interleukin-10 and tumour necrosis…
Positive allosteric modulation of GABAA receptors attenuates high blood pressure in Schlager hyperte…
The Role of the Autonomic Nervous System in the Regulation of Aortic Stiffness.
Augmented Endothelial-Specific L-Arginine Transport Blunts the Contribution of the Sympathetic Nervo…
Major contribution of the medial amygdala to hypertension in BPH/2J genetically hypertensive mice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Proof-of-concept (PoC) Study of APD515
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ